The Food and Drug Administration (FDA) issued an early communication on June 4, 2008 regarding an ongoing safety review of Tumor Necrosis Factor (TNF) Blockers (marketed as Remicade, Enbrel, Humira, and Cimzia) and the possible association between the use of these medicines and the development of lymphoma and other cancers in children and young adults. ...